Abstract
(1) Background: High primary stability is important for the long-term survival of cementless femoral stems in total hip arthroplasty (THA). The objective of this study was to investigate the migration pattern of a hydroxyapatite-coated cementless hip stem developed for minimally invasive surgery using model-based radiostereometric analysis (RSA). (2) Methods: In this randomized controlled trial, 44 patients with an indication for cementless primary THA were randomly allocated to receive either the SL-PLUS MIA stem, developed for minimally invasive surgery, or the SL-PLUS stem (Smith & Nephew Orthopaedics, Baar, Switzerland) which served as a control group. Unlimited weight-bearing was permitted postoperatively in both groups. Model-based RSA was performed after six weeks and after 3, 6, 12 and 24 months postoperatively. (3) Results: Mean total stem subsidence at two-year follow-up was 0.40 mm (SD 0.66 mm) in the SL-PLUS group and 1.08 mm (SD 0.93 mm) in the SL-PLUS MIA group (p = 0.030). Stem subsidence occurred during the first six weeks after surgery, indicating initial settling of the stem under full weight-bearing. Both stem designs showed good osseointegration and high secondary stability with no further migration after initial settling. (4) Conclusions: Settling of a cementless straight femoral stem occurs during the first six weeks after surgery under full weight-bearing. Although initial stem migration was higher in the SL-PLUS MIA group, it had no influence on secondary stability. All implants showed good osseointegration and high secondary stability with no signs of implant loosening during this two-year follow-up period.
Highlights
Abstract: (1) Background: High primary stability is important for the long-term survival of cementless femoral stems in total hip arthroplasty (THA)
The objective of this study was to investigate the migration pattern of a hydroxyapatite-coated cementless hip stem developed for minimally invasive surgery using model-based radiostereometric analysis (RSA). (2) Methods: In this randomized controlled trial, 44 patients with an indication for cementless primary THA were randomly allocated to receive either the SL-PLUS MIA stem, developed for minimally invasive surgery, or the SL-PLUS stem (Smith & Nephew Orthopaedics, Baar, Switzerland) which served as a control group
Initial stem migration was higher in the SL-PLUS MIA group, it had no influence on secondary stability
Summary
1. IntCroedmuecntitolenss total hip arthroplasty (THA) provides excellent long-term results and cementless stemCsehmavenetbleescsotmotealthheipmaortshtrforpeqlausetynt(lTyHuAse)dpriomvpidlaenstesxicnelplernimt laornygT-tHerAmtroedsuaylts[1a]n.dRceegmisetrnytldesastastheamvse hsahvoewbnecthomateatsheeptmicolsotofsreenqiunegntrleymuasiends itmhepmlanotsst icnomprmimoanryreTaHsoAn tfoodr aryev[i1s]i.oRnesguirsgtreyrydaintaThHavAe[s1h].oTwhne tihnaittiaasl empteicchloaonsiceanlinsgtarbeimlitayinosfththeemfoesmt ocoraml mcoomn preoanseonnt foisr raenviismiopnosrutarngterfyacintoTr HfoAr [t1h].e Tlhoengin-tietiraml msuercvhiavnailcoafl sthtaebiimlitpylaonf tt.hHe ifgehmporriaml caormy sptoanbeilnittyisalalonwims pfoorrteaanrltyfapcotostrofpoerrtahteivleonmgo-tbeirlmizastuiornviuvnaldoefr tfhuell iwmepilgahntt-.bHeaigrihngpraimndariys csrtaubciilailtyfoarllooswsesofionrteegarrlaytipoonsbtoypreerdatuivcienmg ombiiclrizoamtioovneumnednetrsfaullol nwgetighheti-mbepalrainntg– abnodneis cinrutecriafalcfeor[o2s].seSotiundteigesratuiosinngbyrraeddiuocsitnergemomicertormicovanemalyensitss a(lRoSnAg)thheaivmepdlaenmt–obnosnteraitnetderftahcaet [2a]n. Sintucdreieasseudsipnogstroapdeiorasttievreeosmteemtrmiciagnraatliyosnisw(RitShAin) thhaevfeirdstemtwoonysteraartsedafttheratsuanrgienrcyrecaasnebdepaosptroepdeicratotirvoef setaemrlymimigpralatinotnfwaiiltuhrien [t3h–e6fi].rsInt tawdodyiteioarns, atoftresriosnuargl eirnystcaabnilbiteyaopf rceedmicetnortloesfseaferlmyoimrapl lcaonmt fpaoilnuernet[s3–c6a]n. IDthuuentsoatiitssfyhiinggh faucnccutriaocnyalanredsuthltes paonsdsipbielritsyisotifnmg etahsiguhrinpgaitnhe[7t–h9re].e-Ddiumeetnosiiotsnahligphosaicticounraocfyananodbjethcet, pRoSsAsihbailsitbyeoenf mweiadseulyrinagcctehpettehdreaes-daigmoelnds-isotannadl paordsittieocnhonfiqauneobfojercat,sRseSsAsinhgasmbeicernowmiodteiolynascocfepotrethdoapseadgioclidm-sptalanndtasridn tveicvhoni[q1u0e,1f1o]r. SBteesmidegseofamcteotrrsyshuachs aasn siumrgpiocratlatnetchimnipqaucetoornbothnee qpuraimlitayr,ystsetmabgileiotymoetfrythheaismanpliamnpt.oTrthaentciemmpeancttleosns thhyedprroimxyaarpyasttiateb-icliotaytoedf tShLe-iPmLpUlSanfet.mTohrealchemipesnytsletesms h(ySdmriotxhy&apNaetipteh-ecwoaOterdthSoLp-aPeLdUicSsfAemG,oBraalahr,ipSwsyitszteermla(nSdm) iitshb&aseNdeopnhethwe Odrutahlo-tpaapeedriecds ,ArGec,tBanaagru, lSawr ictrzoesrsla-snedc)tiiosnbeadsecdononcetphteodfutahle-tZapweereydm, ürellcetarnsgteumla.rScirnocses-istescitniotrnoedduccotniocnepint o1f9t9h4e, Zitwheaysmshüollwernsetexmce.llSeinntcecliitnsicinaltrroedsuuclttsiowniitnh 1a99re4p, iotrhteads schuomwunlaetxivceelsleunrtvcivlionrischailpreosfu9lt6s%wiatth2a0 ryeepaorrste[d12c,u1m3].ulTahtieveSsLu-PrvLiUvoSrsMhiIpAofst9e6m% wata2s0iynetraorsdu[1c2e,d13i]n. GItehoamseatrmyo, dwifiheicdhmisetoappthimysiezaeldstfeomr sgoefot-mtiesstruye, wphreicsehrvisinogptaipmpirzoeadchfoers saonfdt-tiissisnuteenpdreesdertovifnagcialiptaptreoiamchpelasnatnatdioins iwnittehndreeddutcoedfalcaitleitraatlebiomnpelraensteacttiioonn watiththreedgurceeadtelratetrroacl hbaonnteerres(Fecigtiuornea1t )t.heHgorweaetveerrt,rolcithtlaentcelrin(Ficiaglurdea1ta).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
